Opportunities for
Health Services Research at the
National Institute on Drug Abuse
AcademyHealth Annual Research Meeting
June 29, 2010
Boston, MA
Sarah Q. Duffy, Ph.D.
Associate Director of Economics Research
Division of Epidemiology, Prevention, and Services Research
N i
National Institute on Drug Abuse
l I i
D Ab
duffys@nida.nih.gov

Improve the QUALITY of addiction treatment and h
f dd
d
p
prevention services 
“A quality system provides effective services for all who need them at reasonable a cost”
 Availability, access, effectiveness, efficiency, cost
y
y

Results that can be acted upon
Health reform, parity may increase utilization and instigate other wide‐spread changes
g
p
g

Division of Epidemiology, Prevention, and Services Research
 ~ 230 grants in Services Research Branch
 ~ 20 in the Prevention Research Branch

Cli i l T i l N t
Clinical Trials Network ancillary studies
k ill t di

Increasing treatment quality 



Dissemination and implementation of EBPs
Continuity of care within and between providers systems Continuity of care within and between providers, systems Integrated treatment (location and conditions)
Special populations (e.g. women, adolescents, racial/ethnic minorities)  Workforce
 Quality and performance measurement and management




Business practices
E
Economics
i
Effects of public policies, laws, and regulations
HIV/AIDs

Effectiveness studies

Underlying processes and mechanisms of prevention programs and their interactions with client factors
li f

Implementation and adoption of EBPs

Capacity building 
Novel delivery models

W kf
Workforce 
Health Services Research on the Prevention and lh
h
h
d
Treatment of Drug & Alcohol Abuse PA‐08‐263, g
PA‐08‐264, PA‐08‐265 
Economics of Prevention and Treatment for Drug & Alcohol Abuse: PA‐08‐172, ‐173 & ‐174

Mentored Career Development Awards
T
Technical Assistance Webinar July 12
h i l A i t
W bi J l th




Accelerating the Pace of Drug Abuse Research Using A l ti th P f D Ab R
h U i Existing Epidemiology, Prevention, and Treatment R
Research Data (R01
h D t (R ) PAR‐10‐018
PAR
8
Mechanism for Time‐Sensitive Drug Abuse Research g
(R01) PAR 10‐072
Dissemination & Implementation Research in Health PAR‐10‐038, PAR‐10‐039, PAR‐10‐040
Drug Abuse Dissertation Research: Epidemiology Drug Abuse Dissertation Research: Epidemiology, Prevention, Treatment Services and/or Women and Sex/Gender Difference s (R36): PAR 10 020
Sex/Gender Difference s (R36): PAR‐10‐020



Building System Capacity for Implementing B ildi S t C
it f I l
ti Evidence‐Based Practices in Substance Abuse T
Treatment & Prevention (R34): PA‐09‐105 & P
i (R ) PA
Pilot and Feasibility Studies in Preparation for y
p
Drug Abuse Prevention Trials (R34): PA‐09‐146
Drug Abuse Epidemiology and Services Research in Cooperation with the Clinical and Translational Science Awards Consortium (R01) PAS 09 001 Science Awards Consortium (R01): PAS‐09‐001 (R01)

Does increasing HIV testing and reducing viral load among HIV+ individuals reduce transmission rates?

How can this be done?

How much does it cost and is it cost‐effective?

$8,000,000; 
Due 11/15/2010



From concept stage through revision
One on one One‐on‐one Team approach (multiple PO’s or whole branch)
 Regular schedule – every other week
 Adobe Connect Platform

Starts with a concept paper…

Grant Purpose
Mechanism (R01/R03/R43 etc), amount and duration G
P
of funding, institutes/centers/agencies 
Problem & Significance Why this topic needs study, the payoff to Wh this topic needs st d the pa off to science AND public health, why the project is unique and innovative.

Question Specific hypotheses, as well as theories and model(s) that Specific hypotheses as well as theories and model(s) that guide them 
Design & Analysis
g
y Population , interventions, controls, measures, p
,
,
,
,
required sample and power, statistical approach

Team & Logistics How your career stage, expertise, and experience qualify you to lead a project of the size, scope, & technology proposed; lif t l d j t f th i & t h l
d key collaborators; organizations whose cooperation you will need to access subjects/data/equipment/field sites
Thank You!
www.drugabuse.gov
© 2010 Lori Ducharme